PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Immunology and Allergy, Campbelltown Hospital, Sydney, NSW, Australia.\', \'Department of Respiratory Medicine, Concord Hospital, Sydney, NSW, Australia.\', \'Clinical Haematology Unit, Monash Health, Melbourne, VIC, Australia.\', \'Department of Medicine, Campbelltown Hospital, Sydney, NSW, Australia.\', \'Department of Medicine, Concord Hospital, Sydney, NSW, Australia.\', \'Intensive Care Unit, Campbelltown Hospital, Sydney, NSW, Australia.\', \'Department of Respiratory Medicine, Campbelltown Hospital, Sydney, NSW, Australia.\', \'Department of Microbiology and Infectious Diseases, Concord Hospital, Sydney, NSW, Australia.\', \'School of Medicine, Western Sydney University, Sydney, NSW, Australia.\', \'Intensive Care Unit, Concord Hospital, Sydney, NSW, Australia.\', \'Intensive Care Unit, Monash Health, Melbourne, VIC, Australia.\', \'Monash Infectious Diseases, Monash University, Melbourne, VIC, Australia.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1111/1756-185X.13913
?:doi
?:hasPublicationType
?:journal
  • International journal of rheumatic diseases
is ?:pmid of
?:pmid
?:pmid
  • 32881350
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.726
?:rankingScore_hIndex
  • 30
is ?:relation_isRelatedTo_publication of
?:title
  • Tocilizumab for severe COVID-19 pneumonia: Case series of 5 Australian patients.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32881350>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32881350>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all